Biocept Inc reports results for the quarter ended in June - Earnings Summary

Biocept

10/11/2022 22:43

* Biocept Inc  BIOC.OQ  reported a quarterly adjusted loss
of 31
cents​​ per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 16
cents per share.
    * Revenue fell 11.9% to $10.61 million from a year ago;
analysts
expected $12.47 million. 
    * Biocept Inc's reported EPS for the quarter was a loss
of 31
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Biocept Inc shares had fallen by 19.7% this quarter and
lost 79.6% so far this year.
    * The company reported a quarterly loss of $5.25 million.
    * Wall Street's median 12-month price target for Biocept Inc
is
$7.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:42 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.16          -0.31          Missed
 Mar. 31 2022      -0.14          -0.16          Missed
 Dec. 31 2021      -0.19          -0.18          Beat
 Sep. 30 2021      0.07           0.03           Missed